𝗥𝘂𝗿𝗮𝗹 𝗛𝗲𝗮𝗹𝘁𝗵 𝗦𝗽𝗼𝘁𝗹𝗶𝗴𝗵𝘁: 𝗔𝗜𝗥
In a stroke, minutes save lives—and miles can cost them.
More than half of Americans live over an hour from a hospital that can perform a thrombectomy.
Only 12% of eligible patients ever get one.
ARPA-H’s AIR program is building autonomous surgical systems to deliver advanced procedures closer to home.
A specialist visit in rural Utah can consume an entire day.
ARPA-H is shrinking that distance by bringing world-class care closer to home.
HHS Region 8 Director @VictoriaDseaman and Utah DHHS Commissioner Tracy Gruber share why that matters for families across the state.
ARPA-H is making miles matter less in American healthcare.
Rural Health Spotlight — THOR
For rural women with ovarian cancer, care often means long trips to major cancer centers.
ARPA-H is bringing treatment closer.
THOR is building an implant that tracks cancer biomarkers and delivers personalized immunotherapy right near the tumor, cutting down on repeated travel.
Watch to see how THOR is reshaping cancer care.
ARPA-H drives breakthroughs in health and medicine through high-risk, high-reward research. Pleased to welcome @ARPA_H’s Sara Reistadt-Long, Glen Coppersmith, and Amy Lin to Copenhagen for their visit to speak at the Clinical Innovation Summit 2026 and meet with Danish researchers and innovators. We discussed how the U.S. and Denmark can work together on the future of health innovation.
Advanced care shouldn’t be limited by a hospital’s walls.
Proud to be part of @ARPA-H’s PARADIGM program and the team working to bring MARCUS, a mobile hospital, to rural communities.
Exciting to see what’s ahead for rural healthcare!
Across rural America, families often travel long distances to access essential healthcare services. @ARPA_H is investing in breakthrough technologies that bring advanced care closer to home.
This week, follow ARPA-H: Every Mile, Every American as the agency travels across rural communities to highlight the patients, clinicians, and innovations shaping the future of rural healthcare.
Rural Health Spotlight: PARADIGM
Why should advanced care be tied to a hospital building?
ARPA-H is breaking medicine out of the hospital.
PARADIGM’s MARCUS platform is bringing imaging, labs, dialysis, cancer care, OB/GYN services, and more into one mobile system built for rural communities.
Watch to learn how MARCUS is changing the future of rural care.
Rural Health Week hits the road.
In rural America, families travel farther for care—and many never reach it.
ARPA-H is building technologies that bring advanced care closer to home.
This week, follow ARPA-H: Every Mile, Every American as we meet the communities, clinicians, and patients driving this work.
Yesterday, @SecKennedy made announcements on new HHS and @ARPA_H funding that will advance the development of mental health treatments for veterans and civilians including an almost $5 million in ibogaine as a potential PTSD treatment, and $20 million to support research on rapid-acting psychotropics interventional drugs.
Joining Secretary Kennedy for the press conference were @DrOzCMS, @FDA_KyleD, Chief Medical Officer for ARPA-H Dr. Rafid Fadul, Acting Director of the National Institute of Mental Health Dr. Andrea Beckel-Mitchener, and @DeptVetAffairs Senior Advisor Andrew Gradison.
#PittMed researchers and @UPMCHillmanCC received a 2-year, $4.385M @ARPA_H award to explore whether quantum particles generated during radiation therapy can reveal critical real-time information about tumors that conventional imaging may miss.
https://t.co/JMSKZkAHuV
Veterans with PTSD need better options now.
ARPA-H is creating a U.S. clinical research path for ibogaine that has never existed before.
Up to $4.9M will support new awardees @costplusdrugs and @BeondUs in building the foundation for first-in-U.S. trials.
Learn how ARPA-H is advancing ibogaine research ➡️ https://t.co/wMvQwGJn2O
ARPA-H is driving the next evolution of mobile care.
PARADIGM brings SI task guidance, advanced imaging, and hospital-level capabilities on the road.
It is one piece of a larger ARPA-H push to bring cutting-edge care to rural Americans.
Next week, Every Mile, Every American takes you inside the programs built to close the distance to care.
What if the buildings you’re in could help prevent illness?
ARPA-H’s BREATHE program is developing technology to sense airborne threats, assess risk, and respond before people get sick.
A new @WELLcertified spotlight conversation with @Georgetown explores how ARPA-H is making buildings part of proactive health.
Read the story ➡️ https://t.co/FBTPIqXxGM
Veterans and Americans struggling with serious mental illness deserve new hope and better treatment options.
HHS and @ARPA_H are investing up to $4.9M to advance ibogaine research for PTSD, alongside a new $20M funding opportunity to study rapid-acting treatments like ketamine, esketamine, and psilocybin.
.@SecKennedy makes MAJOR ANNOUNCEMENT on investments to advance research into ibogaine as a potential treatment for PTSD!
“@HHSGov is committing up to $4.9 million through @ARPA_H to advance ibogaine treatments for PTSD. These awards will support the scientific, regulatory, and manufacturing work necessary to prepare for future U.S. clinical trials.”
.@SecKennedy on Beond’s role in accelerating ibogaine research:
“Beond, a Texas-based company that operates a hospital in Mexico, has treated more than 3,000 patients and administered 6,000 doses of ibogaine. The company uses evidence-driven, physician-led, hospital-grade treatment protocols, and they’ve agreed to turn that research over to us, specifically to @ARPA_H. That is going to allow us to dramatically accelerate the clinical trial process.”
HAPPENING NOW: @SecKennedy announces new @HHSGov and @ARPA_H actions to advance innovative mental health treatments for veterans and Americans nationwide.
Tune in👇
https://t.co/Zcbl0WZQx5
This Veterans Day, we honor and thank all who have served our country.
For many veterans, PTSD and other behavioral health conditions still mean trial-and-error care. ARPA-H is building first-of-their-kind tools to change that.
Watch our EVIDENT playlist to hear how ARPA-H is creating a new standard for Veterans’ mental health care ➡️ https://t.co/em5bWLZKuu
Diagnosis still waits for symptoms.
ARPA-H is changing that.
Through Delphi, ARPA-H is investing up to $38M in PYTHIA, an MIT-led wearable that uses body heat and on-chip SI to track heart failure and sepsis biomarkers.
More from @MIT ➡️ https://t.co/3OYEs53coD
Exciting news! @RFreeman_Lab has received a 4yr @ARPA_H award through the BIOmolecular Grammar program. The IMPEDE project brings together teams from universities across the US & abroad to tackle protein misfolding diseases. https://t.co/kwlU9umiBc
@UNCPharmacy